Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Organocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101786983A reveals a mild one-pot synthesis for 2-amino-1,2-dihydroisoquinolines using AgOTF and NHC catalysts, offering high purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN113200932B reveals a novel TDAC-catalyzed route for oxazolidinone synthesis, offering metal-free purity and chiral retention for pharmaceutical intermediates.
Patent CN110292948B reveals a metal-free carboxylation method using imidazole salts, offering safer atmospheric pressure synthesis for pharmaceutical intermediates.
Patent CN116606268A reveals high-yield furanone synthesis. Enables cost reduction in pharmaceutical intermediate manufacturing with green catalytic methods for global supply chains.
Patent CN109111380B introduces a transition-metal-free method for synthesizing chiral amines via hydrogen borrowing, offering cost reduction in API manufacturing and high stereoselectivity.
Patent CN101516898B details a novel asymmetric Strecker reaction for L-AMPB production, offering significant cost reduction in herbicide manufacturing and scalable supply chain solutions.
Patent CN100361971C reveals tunable L-proline catalysts for asymmetric aldol reactions, offering metal-free synthesis routes and significant cost reduction in pharmaceutical intermediates manufacturing.
Novel asymmetric synthesis of chiral dihydrofurans via squaric acid catalysis. High enantioselectivity and mild conditions for API manufacturing.
Novel DBU-mediated route eliminates metal catalysts, offering high purity and cost efficiency for reliable pharmaceutical intermediate suppliers.
Patent CN103910737B reveals novel Takemoto catalyzed synthesis. Offers high yield, enantioselectivity, and antibacterial activity for reliable supply chain.
Patent CN118515585A reveals metal-free alkenyl cyanide synthesis. High yield, trans-selective. Reliable supplier for pharma intermediates.
Patent CN111646958B reveals a novel organocatalytic route for carfilzomib intermediates, offering high purity and cost-effective manufacturing solutions for global supply chains.
Patent CN104557583A reveals green quinidine catalysis for high-purity pharmaceutical intermediates ensuring cost reduction and supply chain reliability.
Patent CN101857593A discloses a novel reductive amination route for 9-aminoquinine derivatives, offering high purity and scalable production for pharmaceutical applications.
Patent CN104610218A reveals efficient L-proline catalyzed synthesis. Offers cost reduction and scalable supply for pharmaceutical intermediates manufacturing.
Patent CN109020987B details an iodine-mediated synthesis of chiral pyrazole spirofurans using squaric acid catalysts, offering high yield and selectivity for API manufacturing.
Patent CN107382867B reveals a robust 3-step synthesis for 4-isothiocyanatopyrazolones, enabling cost-effective production of hCE1 inhibitor precursors.
Patent CN113880901B reveals a metal-free asymmetric halocyclization route for high-purity nucleoside intermediates, offering significant cost reduction and supply chain reliability.
Patent CN108147973B details a novel thiourea-catalyzed route for ECPPA, offering superior stereoselectivity and simplified processing for ACE inhibitor manufacturing.
Patent CN112279765B details a novel NHC-catalyzed kinetic resolution for chiral alpha-fluoroketones, offering mild conditions and high efficiency for pharmaceutical intermediate manufacturing.